RxDoctor Payments Data

Joseph Izzo

Internal Medicine · Buffalo, NYNPI 1750481065

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,186 of the $7,675 with a category attached, or 93.6%. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,675in general payments, 2019–2025

Across 7 payments — averaging $1096.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Clarus Therapeutics Inc.$4K
  • Boehringer Ingelheim$3K
$1,567,720in research payments, 2019–2025

Across 124 payments — averaging $12,643 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$784K
  • Merck$318K
  • Boehringer Ingelheim$160K
  • Astrazeneca UK Limited$143K
  • Novartis$58K
  • Lexicon Pharmaceuticals, Inc.$36K
  • plus $68K from 5 others

What the payments were for

  • Speaking & faculty fees$7,18694%
  • Travel & lodging$2593%
  • Food & beverage$2313%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Clarus Therapeutics Inc.6$4,490
Boehringer Ingelheim1$3,186

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,675 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan34$21,943
FarxigaDapagliflozin Propanediol11$6,913

Paid to pharmacies, not to this prescriber.

Other internal medicine in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →